Inventor · disambiguated record
Rene S. Hubert
Also filed as: HUBERT RENE · HUBERT RENE S
116 granted patents·36 pending applications·1,142 citations·filing 1999–2021
99Inventor score
Top patents by PatentIndex Score
152 records- 0199US7485299B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2006·Granted Feb 3, 2009·49 cites·18 claims
- 0298US7507541B236P6D5: secreted tumor antigenAGENSYS INC·Filed 2007·Granted Mar 24, 2009·89 cites·26 claims
- 0398US6329503B1Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 1999·Granted Dec 11, 2001·147 cites·16 claims
- 0497US7641905B2Methods of inducing an immune responseAGENSYS INC·Filed 2005·Granted Jan 5, 2010·25 cites·4 claims
- 0597US7628989B2Methods of inducing an immune responseAGENSYS INC·Filed 2005·Granted Dec 8, 2009·23 cites·4 claims
- 0696US7053186B2Antibodies immunospecific for STEAP1AGENSYS INC·Filed 2001·Granted May 30, 2006·48 cites·7 claims
- 0795US8414898B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAFAR DANIEL E·Filed 2011·Granted Apr 9, 2013·35 cites·24 claims
- 0894US7928201B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2009·Granted Apr 19, 2011·16 cites·20 claims
- 0994US7749746B2Nucleic acid encoding 238P1B2 useful in detecting cancerAGENSYS INC·Filed 2009·Granted Jul 6, 2010·9 cites·11 claims
- 1094US7642054B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2005·Granted Jan 5, 2010·19 cites·21 claims
- 1194US7611904B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2006·Granted Nov 3, 2009·19 cites·39 claims
- 1294US7166714B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2003·Granted Jan 23, 2007·35 cites·6 claims
- 1394US7067130B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2002·Granted Jun 27, 2006·27 cites·12 claims
- 1494US6887975B2Peptides derived from STEAP1AGENSYS INC·Filed 2001·Granted May 3, 2005·40 cites·8 claims
- 1593US7968307B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2009·Granted Jun 28, 2011·14 cites·22 claims
- 1692US7667018B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2007·Granted Feb 23, 2010·10 cites·8 claims
- 1792US7592149B2Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancerAGENSYS INC·Filed 2006·Granted Sep 22, 2009·5 cites·10 claims
- 1892US7226594B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2002·Granted Jun 5, 2007·25 cites·13 claims
- 1992US6943235B1Transmembrane protein expressed in prostate cancerAGENSYS INC·Filed 2000·Granted Sep 13, 2005·34 cites·10 claims
- 2091US7553814B2238P1B2 proteinAGENSYS INC·Filed 2006·Granted Jun 30, 2009·5 cites·3 claims
- 2191US7405290B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2004·Granted Jul 29, 2008·23 cites·14 claims
- 2291US7037667B1Tumor antigen useful in diagnosis and therapy of prostate and colon cancerAGENSYS INC·Filed 2000·Granted May 2, 2006·41 cites·10 claims
- 2391US6893818B1Gene upregulated in cancers of the prostateAGENSYS INC·Filed 2000·Granted May 17, 2005·19 cites·1 claims
- 2489US7575749B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2004·Granted Aug 18, 2009·18 cites·3 claims
- 2589US7223542B236P6D5: secreted tumor antigenAGENSYS INC·Filed 2003·Granted May 29, 2007·13 cites·2 claims
- 2688US6833438B1Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 1999·Granted Dec 21, 2004·45 cites·6 claims
- 2788US6566078B136P6D5: secreted tumor antigenAGENSYS INC·Filed 2000·Granted May 20, 2003·12 cites·10 claims
- 2886US8053551B2Serpentine transmembrane antigens expressed in human cancers and uses thereforAGENSYS INC·Filed 2003·Granted Nov 8, 2011·7 cites·2 claims
- 2986US7771968B2Gene upregulated in cancers of the prostateAGENSYS INC·Filed 2008·Granted Aug 10, 2010·2 cites·9 claims
- 3086US7510840B1Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibodyAGENSYS INC·Filed 2002·Granted Mar 31, 2009·16 cites·7 claims
- 3186US7459539B2Antibody that binds zinc transporter protein 108P5H8AGENSYS INC·Filed 2001·Granted Dec 2, 2008·16 cites·12 claims
- 3286US7455991B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2004·Granted Nov 25, 2008·14 cites·6 claims
- 3385US8562989B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerJAKOBOVITS AYA·Filed 2011·Granted Oct 22, 2013·4 cites·12 claims
- 3485US7947459B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2004·Granted May 24, 2011·19 cites·11 claims
- 3585US7795391B2Protein showing enhanced expression in cancer cellsAGENSYS INC·Filed 2007·Granted Sep 14, 2010·8 cites·6 claims
- 3685US6602501B1C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereofAGENSYS INC·Filed 2000·Granted Aug 5, 2003·13 cites·13 claims
- 3783US8241626B2Serpentine transmembrane antigens expressed in human cancers and uses thereofHUBERT RENE S·Filed 2006·Granted Aug 14, 2012·7 cites·11 claims
- 3883US7449548B2Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancerAGENSYS INC·Filed 2001·Granted Nov 11, 2008·7 cites·5 claims
- 3983US7217799B2Antibodies that recognize the 85P1B3 protein useful in treatment and detection of cancerAGENSYS INC·Filed 2001·Granted May 15, 2007·5 cites·8 claims
- 4083US6924358B2121P1F1: a tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2001·Granted Aug 2, 2005·5 cites·4 claims
- 4181US7879570B2Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancerAGENSYS INC·Filed 2009·Granted Feb 1, 2011·2 cites·5 claims
- 4281US7585505B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2005·Granted Sep 8, 2009·2 cites·14 claims
- 4380US7968099B2Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancerAGENSYS INC·Filed 2009·Granted Jun 28, 2011·0 cites·5 claims
- 4479US7279556B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2004·Granted Oct 9, 2007·3 cites·6 claims
- 4579US7135549B1Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancerAGENSYS INC·Filed 2002·Granted Nov 14, 2006·6 cites·15 claims
- 4678US7732584B2Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancerAGENSYS INC·Filed 2009·Granted Jun 8, 2010·0 cites·11 claims
- 4778US7659377B2Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancerAGENSYS INC·Filed 2008·Granted Feb 9, 2010·1 cites·10 claims
- 4878US7655234B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2005·Granted Feb 2, 2010·1 cites·8 claims
- 4978US7642342B2Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancerAGENSYS INC·Filed 2006·Granted Jan 5, 2010·1 cites·11 claims
- 5078US7501502B2Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancerAGENSYS INC·Filed 2006·Granted Mar 10, 2009·1 cites·11 claims
Showing the top 50 of 152 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →